Compare Abeona Therapeutics Inc (ABEO) vs Kraft Heinz Co (KHC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Abeona Therapeutics Inc vs Kraft Heinz Co — how do they compare? Abeona Therapeutics Inc trades at $7.57 (market cap $421.19M), while Kraft Heinz Co trades at $24.65 (market cap $29.23B). The key difference: Kraft Heinz Co is far larger — about 69.4× Abeona Therapeutics Inc's market cap, and Kraft Heinz Co pays a 6.49% dividend while Abeona Therapeutics Inc pays none. Which is the better fit depends on your goals.
| ABEO | KHC | |
|---|---|---|
Market Cap | $421.19M | $29.23B |
Sector | Health | Consumer Staples |
52-Week High | $7.45 | $28.06 |
52-Week Low | $4.17 | $21.21 |
Enterprise Value | $276.10M | $45.55B |
Dividend Yield | — | 6.49% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Abeona Therapeutics Inc
Abeona Therapeutics develops gene and cell therapies for rare diseases. Its lead product, ZEVASKYN, is an FDA-approved therapy for recessive dystrophic epidermolysis bullosa (RDEB), a severe and life-threatening genetic skin disorder.
Read more on ABEO →About Kraft Heinz Co
In July 2015, Kraft merged with Heinz to create the third-largest food and beverage manufacturer in North America behind PepsiCo and Nestle and the fifth-largest player in the world. Beyond its namesake brands, the combined firm's portfolio includes Oscar Mayer, Velveeta, and Philadelphia. Outside North America, the firm's global reach includes a distribution network in Europe and emerging markets that drive around one fifth of its consolidated sales base, as its products are sold in more than 190 countries and territories.
Read more on KHC →
